Drug company to pay $22.9 million in rebates owed to Washington state

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

SEATTLE (AP) — The state attorney general’s office has announced a national pharmaceutical company accused of underpaying drug rebates owed to Medicaid will pay Washington $22.9 million.

A statement from the state’s legal office Thursday says Wyeth, owned by drugmaker Pfizer Inc., agreed to pay a total of $784.6 million to the federal government and 34 other states for allegedly underpaying rebates required through a federal measure for the sale of two drugs between 2001 and 2006.

Part of Washington’s total $46.7 million haul will go to the federal government, with $22.9 million coming back to the state’s Medicaid program.

Pfizer is headquartered in New York, and Wyeth is headquartered Madison, N.J. They’re both Delaware corporations.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.